Prednisolone sodium phosphate Impurity Isomer 1
 
		Product Description
CAT No.
				
									ALN-P027028								
				CAS No.
				
									NA								
				Mol. F.
				
									C22H29Na2O8P								
				Mol. Wt.
				
									498.4								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : 11α,17-dihydroxy-3,20-dioxopregna-1,4-dien-21-yl disodium phosphate								
				
									Smiles : O=C1C=C[C@@]2(C)C(CC[C@]3([H])[C@]2([H])[C@H](O)C[C@@]4(C)[C@]3(CC[C@@]4(C(COP(O[Na])(O[Na])=O)=O)O)[H])=C1								
				
									Inchi : InChI=1S/C21H26O6/c1-19-7-5-12(22)9-11(19)3-4-13-14-6-8-21(27,17(24)18(25)26)20(14,2)10-15(23)16(13)19/h5,7,9,13-16,23,27H,3-4,6,8,10H2,1-2H3,(H,25,26)/t13-,14-,15-,16+,19-,20-,21-/m0/s1								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Validated stability indicating RP-LC assay for determination of gatifloxacin and prednisolone acetatein ophthalmic preparations and biological samples
									By Qadir, Muhammad A.; Shahzad, Shabnam; Ahmed, Mahmood; Razzaq, Syed S.; Shafiq, Muhmmad I.nFrom Latin American Journal of Pharmacy (2016), 35(5), 912-920								
				Novel stability indicating RP-HPLC method for the simultaneous estimation of moxifloxacin and prednisolone in bulk and their combined dosage form
									By Potnuri, Naga Raju; Rao, G. Devala; Prasad, Y. Rajendra – From International Journal of Pharmaceutical Sciences and Research (2015), 6(5), 1965-1973 								
				Development and validation of a new stability indicating reversed phase liquid chromatographic method for the determination of prednisolone acetate and impurities in an ophthalmic suspension
									By Marley, Adrian; Stalcup, Apryll M.; Connolly, Damian – From Journal of Pharmaceutical and Biomedical Analysis (2015), 102, 261-266								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            